This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event September 21-24, 2021
In-Person: September 21-22 • Virtual: September 23-24Renaissance Boston Waterfront Hotel • Boston, MA

Patrick Mooty
Vice President, Compliance & Ethics at Sumitomo Dainippon Pharma America

Profile

Patrick Mooty leads the team that provides healthcare compliance and transparency reporting services to certain affiliates of Sumitomo Dainippon Pharma Group, including Sunovion Pharmaceuticals and SDP Oncology.   

Prior to joining Sunovion in 2016, Patrick was Global Compliance Officer for HeartWare (now Medtronic).  Patrick guided the US and international medical and commercial teams, and third party distributors, on the research, development and commercialization of the HVAD ventricular assist device, approved in 56 countries to treat advanced heart failure patients. 

Prior to joining HeartWare in 2011, Patrick was Senior Director of Ethics and Compliance at Fresenius Medical Care, the world's largest integrated provider of dialysis products and services. Patrick led compliance efforts for the US medical devices business, and established the compliance program for Fresenius’ new Renal Pharmaceuticals entity.

Prior to joining Fresenius in 2004, Patrick was an attorney specializing in regulatory compliance and taxation matters.  He is a graduate of the University of Pennsylvania Carey Law School and Dartmouth College.



Agenda Sessions

  • Compliance Considerations on the Future of Medical Meetings

    11:00am